13F HOLDINGS REPORT
Checkpoint Capital L.P.
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001977548-24-000006
Total Value
$149.6M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | RHYTHM PHARMACEUTICALS INC | RYTM | 825,500 | $35.8M | 23.91% |
| 2 | ARGENX SE | ARGX | 82,000 | $32.3M | 21.58% |
| 3 | CYTOKINETICS INC | CYTK | 190,000 | $13.3M | 8.90% |
| 4 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 701,387 | $11.8M | 7.92% |
| 5 | AXSOME THERAPEUTICS INC | AXSM | 132,437 | $10.6M | 7.06% |
| 6 | MIRUM PHARMACEUTICALS INC | MIRM | 362,193 | $9.1M | 6.08% |
| 7 | PROTAGONIST THERAPEUTICS INC | PTGX | 280,301 | $8.1M | 5.42% |
| 8 | CORCEPT THERAPEUTICS INC | CORT | 273,776 | $6.9M | 4.61% |
| 9 | IRONWOOD PHARMACEUTICALS INC | IRWD | 618,528 | $5.4M | 3.60% |
| 10 | PHATHOM PHARMACEUTICALS INC | PHAT | 445,161 | $4.7M | 3.16% |
| 11 | ATYR PHARMA INC | ATYR | 1,446,477 | $2.8M | 1.89% |
| 12 | VERASTEM INC | VSTM | 168,739 | $2.0M | 1.33% |
| 13 | GH RESEARCH PLC | GHRS | 185,653 | $2.0M | 1.32% |
| 14 | TREVI THERAPEUTICS INC | TRVI | 506,082 | $1.7M | 1.17% |
| 15 | APPLIED THERAPEUTICS INC | 03828A101 | 220,000 | $1.5M | 1.00% |
| 16 | ALLAKOS INC | 01671P100 | 767,964 | $967,635 | 0.65% |
| 17 | ATARA BIOTHERAPEUTICS INC | ATRA | 892,853 | $619,640 | 0.41% |